Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.77 |
| ▸ | TSHR | P16473 | 1/20 | 0.77 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.52 |
| ▸ | ACP1 | P24666 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA5A | P35218 | 1/20 | 0.49 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.49 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.49 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.49 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.49 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.47 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.47 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31219335 | 1.00 | ALDH1A1 (0.77) | ALDH1A1TDP1CYP3A4TSHRGAA | |
| SCHEMBL334808 | 0.87 | ALDH1A1 (1.00) | ALDH1A1TDP1CYP3A4TSHRGAA | |
| SCHEMBL2172967 | 0.87 | SMN1; SMN2 (0.75) | ALDH1A1TDP1CYP3A4TSHRGAA | |
| Nitrogen SCHEMBL28651597 | 0.84 | ALDH1A1 (0.94) | ALDH1A1TDP1CYP3A4TSHRGAA | |
| SCHEMBL5049722 | 0.83 | ALDH1A1 (0.86) | ALDH1A1TDP1CYP3A4TSHRGAA | |
| SCHEMBL23926457 | 0.81 | RIPK1 (0.53) | ALDH1A1TDP1CYP3A4TSHRRIPK1 | |
| Sulfuric Acid SCHEMBL28206216 | 0.80 | ALDH1A1 (0.86) | ALDH1A1TDP1CYP3A4TSHRGAA | |
| SCHEMBL29361660 | 0.80 | RIPK1 (0.52) | ALDH1A1TDP1CYP3A4TSHRRIPK1 | |
| SCHEMBL2002714 | 0.80 | RIPK1 (0.52) | ALDH1A1TDP1CYP3A4TSHRRIPK1 | |
| SCHEMBL617121 | 0.80 | RIPK1 (0.52) | ALDH1A1TDP1CYP3A4TSHRRIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109535044-B | Diazotization method of aromatic primary amine | 金华双宏化工有限公司 | 2021-06-15 | — | — | CN | claimed |
| CN-110387141-B | Azo cationic reactive dye with dye matrix being benzothiazole, preparation and application thereof | 东华大学 | 2020-12-18 | — | — | CN | claimed |
| CN-101391987-B | Two-dimension azo heterocycles chromophores and synthetic method thereof | UNIV SOUTHEAST | 2011-07-20 | — | — | CN | claimed |
| CN-101391987-A | Two-dimension azo heterocycles chromophores and synthetic method thereof | UNIV SOUTHEAST (CN) | 2009-03-25 | — | — | CN | claimed |
| EP-0100008-A1 | Azo dyestuffs, their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1984-02-08 | — | — | EP | claimed |
| EP-0087037-A1 | Azo-dyestuffs | BAYER AG (DE) | 1983-08-31 | — | — | EP | claimed |
| CN-121950015-A | Carbon fiber reinforced polyether-ether-ketone self-lubricating composite material and preparation method and application thereof | 中国科学院兰州化学物理研究所 | 2026-05-01 | — | — | CN | disclosed |
| EP-4289830-B1 | NLRP3 INFLAMMASOME SMALL-MOLECULE INHIBITOR FOR TREATMENT OF ALZHEIMER'S DISEASE | UNIV AJOU IND ACADEMIC COOP FOUND (KR) | 2026-04-08 | — | — | EP | disclosed |
| US-12590071-B2 | Hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-03-31 | — | — | US | disclosed |
| CN-119707861-A | 2-Substituted aminobenzothiazole compound and application thereof | 沈阳药科大学 | 2025-03-28 | — | — | CN | disclosed |
| WO-2025031129-A1 | ARYL UREA DERIVATIVE, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF | 沈阳药科大学 | 2025-02-13 | — | — | WO | disclosed |
| CN-118359602-A | Aryl urea derivative and application thereof | 沈阳药科大学 | 2024-07-19 | — | — | CN | disclosed |
| EP-4008790-B1 | MONOAZO DYES WITH CYCLIC AMINE AS FLUORESCENCE QUENCHERS | ENZO BIOCHEM INC (US) | 2024-07-17 | — | — | EP | disclosed |
| EP-0025190-B1 | CHROMOGENIC COMPOUNDS AND THEIR USE AS ENZYMATIC SUBSTRATES | BEHRINGWERKE Aktiengesellschaft (DE) | 1984-06-13 | — | — | EP | disclosed |
| EP-0100008-A1 | Azo dyestuffs, their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1984-02-08 | — | — | EP | disclosed |
| EP-0087037-A1 | Azo-dyestuffs | BAYER AG (DE) | 1983-08-31 | — | — | EP | disclosed |
| EP-0039835-B1 | PROCESS FOR THE PREPARATION OF 2-AMINO-6-NITRO-BENZOTHIAZOLE | BAYER AG (DE) | 1983-03-09 | — | — | EP | disclosed |
| US-4369324-A | Process for the preparation of 2-amino-6-nitrobenzothiazole | BAYER AKTIENGESELLSCHAFT (DE) | 1983-01-18 | — | — | US | disclosed |
| EP-0039835-A1 | Process for the preparation of 2-amino-6-nitro-benzothiazole | BAYER AG (DE) | 1981-11-18 | — | — | EP | disclosed |
| EP-0025190-A2 | Chromogenic compounds and their use as enzymatic substrates | BEHRINGWERKE Aktiengesellschaft (DE) | 1981-03-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590071-B2 | Hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof | ABL1, TH, CYP3A43 | ALDH1A1 1008/4885TDP1 2058/4885CYP3A4 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.